Open access
73
Views
5
CrossRef citations to date
0
Altmetric
Short Report
Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
Shannon Cope1 MAPI Consultancy, Boston, MA, USA
, Matthias Kraemer2 Novartis Pharmaceuticals, Basel, Switzerland
, Jie Zhang3 Novartis Pharmaceuticals, East Hanover, NJ, USA
, Gorana Capkun-Niggli2 Novartis Pharmaceuticals, Basel, Switzerland
& Jeroen P Jansen1 MAPI Consultancy, Boston, MA, USACorrespondence[email protected]
Pages 415-420
|
Published online: 05 Jul 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.